NSRGY (NSRGY) Stock Price & Analysis
NSRGY (NSRGY) rose 1.83% to USD 97.42 as of June 9, 2026 at 23:44 UTC, according to Nexqual real-time market data.
NSRGY last closed at USD 95.67; the session ranged USD 97.01–98.08 on volume of 49,371 shares. Market capitalization is $250.59B, with a 52-week range of USD 86.98–109.59 (OID). Source: Nexqual, June 9, 2026 at 23:44 UTC.
Key Statistics (as of June 9, 2026 at 23:44 UTC)
| Price | USD 97.42 |
|---|---|
| Change | ▲ 1.83% (up) |
| Previous Close | USD 95.67 |
| Open | USD 97.12 |
| Day Range | USD 97.01 – 98.08 |
| 52-Week Range | USD 86.98 – 109.59 |
| Volume | 49,371 shares |
| Market Cap | $250.59B |
| Exchange | OID |
Technical Analysis (NSRGY)
Nexqual's technical model rates NSRGY "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 9, 2026 at 23:44 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 46.78 (neutral) |
| vs SMA50 | Below (USD 99.55) |
| MACD | -0.79 (negative) |
Analyst Ratings (NSRGY)
Wall Street analysts rate NSRGY "Buy" based on 5 analysts, with a mean price target of USD 113.2 (range USD 94–128), per Nexqual as of June 9, 2026 at 23:44 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 5 |
| Mean Target | USD 113.2 |
| High Target | USD 128 |
| Low Target | USD 94 |
| Buy / Hold / Sell | 3 / 1 / 1 |
Earnings (NSRGY)
| Revenue Estimate | $21.17B |
|---|
Source: Nexqual, June 9, 2026 at 23:44 UTC.
Financials & Fundamentals (NSRGY)
| Total Revenue | $89.88B |
|---|---|
| Revenue Growth (YoY) | -2.20% |
| Gross Margin | +45.83% |
| Operating Margin | +14.89% |
| Profit Margin | +10.05% |
| ROE | +26.53% |
| Debt / Equity | 175 |
| Current Ratio | 0.79 |
| Total Cash | $6.23B |
| Total Debt | $57.85B |
| Free Cash Flow | $6.24B |
Source: Nexqual, June 9, 2026 at 23:44 UTC.
Financial Health Score (NSRGY)
Nexqual rates NSRGY's overall financial health "Mixed" across five dimensions, as of June 9, 2026 at 23:44 UTC.
| Growth | Weak — Revenue -2% YoY (annual), declining |
|---|---|
| Profitability | Strong — Gross margin 46%, operating 15% |
| Balance Sheet | Critical — $6.23B cash vs $57.9B debt |
| Cash Flow | Solid — FCF $6.24B, 7% margin |
| Efficiency | Strong — ROE 27%, ROA 6.5% |
Ownership (NSRGY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.96% |
| Shares Outstanding | 2.57B |
| Float | 2.57B |
Source: Nexqual, June 9, 2026 at 23:44 UTC.
Leadership (NSRGY)
NSRGY is led by Philipp Navratil (age 49), CEO & Member of the Executive Board, per Nexqual as of June 9, 2026 at 23:44 UTC.
| CEO & Member of the Executive Board | Philipp Navratil (age 49) |
|---|---|
| Executive VP, CFO & Member of Executive Board | Anna Olive Magdelene Manz (age 52) |
| Executive VP, CTO & Member of Executive Board | Stefan Palzer (age 56) |
Major Backers & Investors (NSRGY)
Notable institutional backers of NSRGY include Gardner Russo & Quinn, LLC, Franklin Custodian Funds-FRANKLIN INCOME FUND, WASHINGTON MUTUAL INVESTORS FUND, according to Nexqual as of June 9, 2026 at 23:44 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Gardner Russo & Quinn, LLC | 0.21% |
| Franklin Custodian Funds-FRANKLIN INCOME FUND | 0.16% |
| WASHINGTON MUTUAL INVESTORS FUND | 0.14% |
| Legg Mason Part. Investment TRT-ClearBridge Dividend Strategy Fd. | 0.13% |
Source: Nexqual, June 9, 2026 at 23:44 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| UL | Unilever PLC | USD 57.58 | ▲ 1.52% |
| RHHBY | Roche Holding Ltd | USD 50.01 | ▼ 2.86% |
| DEO | Diageo plc | USD 80.41 | ▼ 0.02% |
| NVS | Novartis AG | USD 149.12 | ▼ 0.03% |
| LVMUY | LVMH-Moet Hennessy Louis Vuitto | USD 114 | ▲ 3.73% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:44 UTC. This page is informational and not investment advice.